Scarica l'app Stockscreener
0.9495
5.50%
0.0495
Dopo l'orario di chiusura:
.95
0.0005
+0.05%
Precedente Chiudi:
$0.90
Aprire:
$0.8573
Volume 24 ore:
12,131
Relative Volume:
0.07
Capitalizzazione di mercato:
$34.34M
Reddito:
-
Utile/perdita netta:
$-8.53M
Rapporto P/E:
-3.901
EPS:
-0.2434
Flusso di cassa netto:
$-12.75M
1 W Prestazione:
+15.78%
1M Prestazione:
-1.09%
6M Prestazione:
-15.97%
1 anno Prestazione:
-40.66%
Intervallo 1D:
$0.8573
$0.9495
Intervallo di 1 settimana:
$0.825
$0.9495
Portata 52W:
$0.63
$3.23
Estrella Immunopharma Inc Stock (ESLA) Company Profile
Nome
Estrella Immunopharma Inc
Settore
Industria
Telefono
(510) 318-9098
Indirizzo
5858 HORTON STREET, SUITE 370, EMERYVILLE
Confronta ESLA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ESLA
Estrella Immunopharma Inc
|
0.9495 | 31.61M | 0 | -8.53M | -12.75M | -0.2434 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.27 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.64 | 61.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.00 | 42.46B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.74 | 35.22B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
296.46 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Estrella Immunopharma Inc Borsa (ESLA) Ultime notizie
Will Estrella Immunopharma Inc. stock benefit from interest rate changesUnstoppable trading performance - jammulinksnews.com
What analysts say about Estrella Immunopharma Inc. stockMarket-leading growth rates - jammulinksnews.com
What drives Estrella Immunopharma Inc. stock priceFree Stock Chart Pattern Guide - jammulinksnews.com
Estrella Immunopharma Inc. Stock Analysis and ForecastFree Stock Market Return Analysis - jammulinksnews.com
Is Estrella Immunopharma Inc. a good long term investmentDynamic portfolio growth - jammulinksnews.com
Why Estrella Immunopharma Inc. stock attracts strong analyst attentionLong Term Secure Gain Stocks - Newser
How Estrella Immunopharma Inc. stock performs during market volatilityHigh Yield Stock Selection - Newser
how estrella immunopharma inc. stock performs during market volatilityCapital Efficient Investment Tips - Newser
Is Estrella Immunopharma Inc. stock overhyped or has real potentialSolid Return Trade Selections - Newser
What makes Estrella Immunopharma Inc. stock price move sharplyTop Growth Low Risk Stocks - Newser
Estrella Immunopharma Expands STARLIGHT-1 Trial with New Texas Clinical Site - MSN
Estrella Immunopharma opens new trial site for cancer therapy By Investing.com - Investing.com South Africa
Estrella Immunopharma Announces Activation of Additional Site for Phase I/II Starlight-1 Trial in B-Cell Non-Hodgkin's Lymphoma - MarketScreener
Estrella Immunopharma Announces Activation of Additional Site for Phase I/II STARLIGHT-1 Trial in B-cell Non-Hodgkin’s Lymphoma - BioSpace
Estrella Immunopharma (ESLA) Expands Clinical Trial with New Sit - GuruFocus
Estrella Immunopharma opens new trial site for cancer therapy - Investing.com Australia
Estrella Immunopharma Expands STARLIGHT-1 Clinical Trial - TipRanks
Estrella Immunopharma Announces Activation Of Additional Site For Phase I/Ii Starlight-1 Trial In B-Cell Non-Hodgkin'S Lymphoma - marketscreener.com
Estrella Immunopharma secures $3.35M in financing to advance clinical triall; shares up - MSN
Analyst Maintains Buy Rating on Estrella Immunopharma (ESLA) | E - GuruFocus
Estrella Immunopharma secures $3.35 million in PIPE financing By Investing.com - Investing.com South Africa
Analyst Maintains Buy Rating on Estrella Immunopharma (ESLA) | ESLA Stock News - GuruFocus
Estrella Immunopharma (ESLA) Secures $3.35M Through Private Equi - GuruFocus
Estrella Immunopharma secures $3.35 million in PIPE financing - Investing.com Australia
Estrella Immunopharma Inc Azioni (ESLA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.32%
1.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):